Form 4: Director Scott R. Ward Receives Merit Medical RSU Grant

Director Scott R. Ward was granted 3,457 restricted stock units under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan.

Summary

• Director Scott R. Ward acquired 3,457 restricted stock units (RSUs) of Merit Medical Systems, Inc. (MMSI).
• The grant was issued under the 2026 Equity Incentive Plan.
• The RSUs are scheduled to vest on May 3, 2027, contingent upon continued service to the company.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of immediate market impact.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified.

Risks

• Vesting is subject to continued service, creating a dependency on the director's ongoing tenure.

Future Outlook

The filing does not provide forward-looking financial guidance, focusing solely on the equity compensation of a director.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices designed to incentivize long-term oversight and strategic alignment within the medical device sector.

Comparison to Industry Standards

• The use of RSU grants for board compensation is consistent with standard practices for mid-to-large cap medical technology companies.
• Vesting periods of approximately one year are common for annual director equity awards.

Corporate Governance

Stakeholder Impact

• Shareholders: Minimal impact; reflects standard director compensation practices.

Next Steps

• Vesting of the 3,457 RSUs on May 3, 2027.

Key Dates

Keywords

Merit Medical Systems, MMSI, Form 4, Insider Transaction, Restricted Stock Units, Equity Incentive Plan